LGALS3 and pulmonary arterial hypertension: Several studies have shown that the plasma Galectin-3 (Gal-3) level, which is a key fibroblast activation factor, is significantly increased in PAH patients and that Gal-3 expression is upregulated in the adventitia of pulmonary arteries.